Dr Lee Hong Moi
Oncology
Dr Lee Hong Moi is a Oncology specialist practising at Tung Shin Hospital, Prince Court Medical Centre in Kuala Lumpur, Malaysia. MedBay can arrange an appointment at no cost to you.
About
Dr. Lee Hong Moi is a Clinical Oncologist at Prince Court Medical Centre, where she specialises in advanced radiation oncology techniques including Stereotactic Body Radiation Therapy (SBRT), Total Body Irradiation (TBI), Total Marrow Irradiation (TMI), and Total Skin Irradiation (TSI). Her patient-centered philosophy blends cutting-edge science with compassionate care. She has demonstrated leadership in research projects and participated in numerous clinical trials, and she has received an Excellence of Service Award from the Ministry of Health.
Where Dr Lee Hong Moi practises
- Tung Shin Hospital — Kuala Lumpur, Kuala Lumpur
- Prince Court Medical Centre — Kuala Lumpur, Kuala Lumpur
Procedures & Expertise
- Oncology Consultation
- Colon/Bowel Cancer Treatment
- Thyroid Cancer Treatment
- Multiple Myeloma Treatment
- Pancreatic Cancer Treatment
- Treatment for Cancer of Unknown Primary (CUP)
- Endometrial Cancer Treatment
- Nasopharyngeal Cancer Treatment
- Primary Bone Cancer Treatment
- Paranasal Sinus and Nasal Cavity Cancer Treatment
- Hormone Therapy for Cancer
- Male Breast Cancer Treatment
- Chemotherapy
- Cancer Screening
- Small Intestine Cancer Treatment
- Esophageal Cancer Treatment
- Vulvar Cancer Treatment
- Bile Duct Cancer Treatment
- Acute Leukemia Treatment
- Head and Neck Cancer Treatment
- Bone Marrow Aspiration
- Breast Cancer Treatment
- Laryngeal Cancer Treatment
- Penile Cancer Treatment
Qualifications
- MD (Universiti Putra Malaysia)
- Master of Clinical Oncology (University of Malaya)
- Clinical Fellowship in Advanced Radiation Oncology Techniques (Far Eastern Memorial Hospital, Taiwan)
- Malaysian Medical Council (MMC) No. 50567
- National Specialist Register (NSR) No. 138607
- Credentials for external beam radiotherapy, high dose rate brachytherapy for gynaecology cancer, intensity modulated radiotherapy, and specialized radiotherapy procedures such as stereotactic body radiotherapy
- ICH GCP Obligations of Investigators Conducting Clinical Trials (2022)
- Member of European Society for Medical Oncology (ESMO) since 2016
- Member of Malaysian Oncological Society (MOS) since 2016
- Member of American Society of Clinical Oncology (ASCO) since 2020
- Member of Academy of Medicine of Malaysia since 2021
- Member of Malaysian Medical Association (MMA) since 2022
Languages
Mandarin, Indonesian, Malay, English, Cantonese